PRSS50 and colorectal carcinoma: A statistically significant survival difference between high and low TSP50 expression was not observed for CRC patients in advanced stage (stage III and IV; Figure 5D), but studies with larger samples are needed to assess the prognostic importance of TSP50 expression in patients with CRC of this stage.